Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors

Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors

<p>Abstract</p> <p>Background</p> <p>New, more effective strategies are needed to treat highly aggressive neuroblastoma. Our laboratory has previously shown that full-length Secreted Protein Acidic and Rich in Cysteine (SPARC) and a SPARC peptide corresponding to the fo...

Full description

Bibliographic Details
Main Authors: Tian Yufeng, Yang Qiwei, Leonhardt Payton T, Spitz Jared A, Peddinti Radhika, Guerrero Lisa J, Chlenski Alexandre, Salwen Helen R, Cohn Susan L
Format: Article
Language:English
Published: BMC 2010-06-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/9/1/138

Internet

http://www.molecular-cancer.com/content/9/1/138

Similar Items